Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 May;30(3):377-386.
doi: 10.1097/MOU.0000000000000743.

Utilization of imaging for staging in bladder cancer: is there a role for MRI or PET-computed tomography?

Affiliations
Review

Utilization of imaging for staging in bladder cancer: is there a role for MRI or PET-computed tomography?

Stefano Cipollari et al. Curr Opin Urol. 2020 May.

Abstract

Purpose of review: Accurate staging of bladder cancer is essential to guide appropriate management. In this review, we discuss the principles, applications and performance of multiparametric MRI (mpMRI) and PET-computer tomography (PET-CT) for local and distant staging of bladder cancer.

Recent findings: Bladder mpMRI has a high diagnostic performance in local staging of bladder cancer, superior to other imaging modalities. It can accurately differentiate muscle invasive bladder cancer (MIBC) from non-MIBC (NMIBC), as well as ≤T2 from ≥T3 stages. mpMRI can be used to assess pelvic lymph nodes, although its sensitivity is relatively low. For the assessment of the upper urinary tract, CT urography is the imaging modality of choice. magnetic resonance urography is a viable alternative to CT in selected cases. Although PET-CT is accurate for nodal and distant staging of bladder cancer, there is no clear evidence on its superior diagnostic performance compared with contrast-enhanced CT.

Summary: mpMRI is the most accurate imaging modality for local staging of bladder cancer, capable to accurately distinguish MIBC from NMIBC. Nodal and distant staging relies primarily on contrast-enhanced CT.

PubMed Disclaimer

References

    1. Kaufman DS, Shipley WU, Feldman AS. Bladder cancer. Lancet 2009; 374:239–249.
    1. Magers MJ, Lopez-Beltran A, Montironi R, et al. Staging of bladder cancer. Histopathology 2019; 74:112–134.
    1. Babjuk M, Burger M, Compérat E, et al. European Association of Urology Guidelines. 2018 ed.Arnhem, The Netherlands: European Association of Urology Guidelines Office; 2018.
    1. Witjes JA, Bruins M, Compérat E, et al. European Association of Urology Guidelines. 2018 ed.Arnhem, The Netherlands: European Association of Urology Guidelines Office; 2018.
    1. Richterstetter M, Wullich B, Amann K, et al. The value of extended transurethral resection of bladder tumour (TURBT) in the treatment of bladder cancer: value of extended turbt for treating bladder cancer. BJU Int 2012; 110:E76–E79.

MeSH terms